Subject(s)
Receptors, Cholinergic/physiology , Receptors, GABA/physiology , Respiration/physiology , Animals , Cats , GABA Antagonists/pharmacology , Injections, Intraventricular , Lobeline/pharmacology , Naloxone/pharmacology , Picrotoxin/pharmacology , Receptors, Cholinergic/drug effects , Respiration/drug effects , Tubocurarine/pharmacologyABSTRACT
Synthetic analogue thyroliberin (PR-546) devoid of hormonal activity, recovered respiration in conditions of hyperventilation, two-sided vagotomy and hypoxia, caused by the 40-70% bleeding. PR-546 (in doses 100-500 micrograms/kg) intravenously injected was shown to abolish diagram activity decreased effect after hyperventilation. Injection of PR-546 to vagotomized cats in 1.5-2 h, increased breathing rate. The breathing activity resumed after long breaks in respiration as a result of peptide injection. The responses to analogue introductions is similar to the thyroliberin effect.
Subject(s)
Respiration/drug effects , Animals , Cats , Hyperventilation/physiopathology , Shock, Hemorrhagic/physiopathology , Thyrotropin-Releasing Hormone/pharmacology , VagotomyABSTRACT
Controlled lung hyperventilation in cats inhibited the activity of the diaphragm muscle with a subsequent stop of respiration after the end of hyperventilation. Thyroliberin (20-30 mg/kg) intravenously was shown to abolish these effects 15-20 min after application. Preliminary introduction of thyroliberin prevented the changes in the respiration rate and depth caused by vagotomy.